Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews Protocol - Intervention

Sevoflurane versus other general anaesthesia on postoperative behaviour disturbance in children

This is not the most recent version

Collapse all Expand all

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To compare sevoflurane with other general anaesthetic agents, with or without pharmacological adjuncts, with regard to postoperative behavioural disturbance (emergence delirium or other maladaptive behaviours) occurring in children during their PACU stay.

Background

Sevoflurane is an inhaled volatile anaesthetic that is widely used in paediatric anaesthetic practice. First described in 1975 (Wallin 1975), its use commenced in Japan in 1992 and became widespread in 1995 (Holzki 1999). Sevoflurane is a non‐pungent, insoluble agent which facilitates smooth, rapid induction and emergence (Holzki 1999; Johr 2002). However, since its introduction postoperative behavioural disturbance, observed predominantly in the paediatric population (Cole 2002; Voepel‐Lewis 2003), has become an important clinical issue. Some studies suggest that sevoflurane has the highest incidence of behavioural disturbance of all current general anaesthetics while others show conflicting results (Abbotts 2006; Foesel 2001; Johr 2002; Vlajkovic 2006).

These behavioural changes have been described in the literature using a variety of descriptive terms, such as: emergence delirium, postanaesthetic excitation, postoperative delirium and emergence agitation. There is no consensus regarding a definition (Cole 2002; Vlajkovic 2006) however the condition can be described as a mental disturbance during the recovery from general anaesthesia that consists of hallucinations, delusions and confusion manifested by moaning, restlessness, involuntary physical activity and thrashing about in the bed (Sikich 2004). For the purpose of this systematic review, the term 'emergence delirium' will be used to encompass this clinical entity. Until recently there has been no reliable and validated scale to measure emergence delirium. Concern has been expressed as to the reliability of research results and the ease of comparing studies. In 2004 the Paediatric Anaesthesia Emergence Delirium scale was developed and evaluated; it is now a reliable and valid measure of emergence delirium in children (Sikich 2004).

The potential adverse effects of emergence delirium are mostly short lived (Veyckemans 2001). It would also be unusual for children with emergence delirium to be discharged from the postanaesthetic care unit (PACU) as a restless child may cause self‐injury, the dressing or surgical site may be disrupted and indwelling devices have the potential to become dislodged. To prevent such outcomes the child may require pharmacological or physical restraint. Pharmacological management has the disadvantage of exposing the child to medications such as opioids and sedatives. These drugs could themselves have adverse effects and their administration could delay discharge from PACU or hospital. The psychological and long‐term consequences of emergence delirium are largely unknown but it has been suggested that maladaptive behaviours, for example withdrawal, sleeping and eating problems, may be associated with emergence delirium (Holzki 1999; Kain 2004). Extra care is required to manage a patient with emergence delirium, which could strain already limited nursing resources. Care‐givers are at risk of injury when managing these children and may also feel dissatisfied with the quality of anaesthetic care. Parents who witness emergence delirium may become concerned regarding future anaesthetic experiences for their child (Houck 2005). The additional costs and the potential delay to discharge may also be significant.

The exact aetiology of emergence delirium remains unclear, however research to date suggests that there are numerous predisposing factors (Voepel‐Lewis 2003). Anaesthetic factors include: rapid emergence and the intrinsic characteristic of the anaesthetic. The newer volatile anaesthetic agents, such as sevoflurane, allow faster emergence which potentially results in early manifestation of acute pain and anxiety (Wells 1999). Some authors have suggested that sevoflurane exerts a stimulating or even neurotoxic effect on the central nervous system (Constant 1999; Johr 2002; Vlajkovic 2006). Patient‐related factors include: age, preoperative anxiety and the temperament of the child. The incidence of emergence delirium is highest in preschoolers, potentially because of psychological immaturity in this age group (Voepel‐Lewis 2003). Surgical‐related factors include: pain and type of surgery. Pain may increase the incidence of emergence delirium (Lynch 1998) and the behaviour of a child in pain may mimic emergence delirium. Otorhinolaryngology and ophthalmological procedures carry an increased risk of emergence delirium, however this phenomenon has been observed even after non‐painful imaging procedures (Voepel‐Lewis 2003).

Sevoflurane may be a major contributory factor in the development of emergence delirium. Therefore, an evidence‐based understanding of the risk benefit profile regarding sevoflurane compared with other general anaesthetic agents and adjuncts would facilitate its rational and optimal use.

Objectives

To compare sevoflurane with other general anaesthetic agents, with or without pharmacological adjuncts, with regard to postoperative behavioural disturbance (emergence delirium or other maladaptive behaviours) occurring in children during their PACU stay.

Methods

Criteria for considering studies for this review

Types of studies

We will include all randomized and quasi‐randomized, published and unpublished controlled clinical studies.

Types of participants

We will include children less than 18 years of age presenting for general anaesthesia with or without surgical intervention.

Types of interventions

We will include any sevoflurane anaesthetic with or without nitrous oxide compared with any other general anaesthetic with or without nitrous oxide.

The types of general anaesthetics could include other volatile anaesthetics, for example isoflurane, desflurane and halothane; and any other general anaesthetics, for example ketamine.

Types of outcome measures

Primary outcomes

The number of patients with postoperative behaviour disturbance as measured by the authors of the included studies. Emergence delirium will be defined as stated above: a mental disturbance during the recovery from general anaesthesia consisting of hallucinations, delusions and confusion manifested by moaning, restlessness, involuntary physical activity and thrashing about in the bed.

Secondary outcomes

  • Number of patients with other, new onset maladaptive behaviours (e.g. sleep or eating disturbance, poor concentration) in the postoperative period, as measured by the authors of included studies.

  • Number of patients with emergence delirium in the postoperative period after leaving the PACU, as measured by the authors of included studies.

Search methods for identification of studies

Electronic searches

We will search the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library) and the following electronic medicine, nursing, psychology and medical databases (from date of inception): MEDLINE (1966 to present), EMBASE, CINAHL, EBMR and the web of science.

We will search MEDLINE using MeSH headings and text words shown in Appendix 1. We will combine the search with the Cochrane highly sensitive search strategy phases one and two as contained in the Cochrane Handbook for Reviews of Interventions (Higgins 2005).

We will adapt the other databases as appropriate.

We will search for ongoing clinical trials and unpublished studies via Internet searches on the following sites:
1. http://www.controlled‐trials.com;
2. http://www.update‐software.com;
3. http://clinicalstudyresults.org;
4. http://centrewatch.com.

Searching other resources

Trials will also be identified by:
1. manual searching, relevant conference proceedings abstracts will be searched;
2. snowballing, reference list of relevant articles will be checked;
3. contacts, relevant trial authors will be contacted by e‐mail to identify additional studies.

We will not apply language or publication restrictions.

Data collection and analysis

Selection of studies

Authors will identify titles and abstracts of studies in the initial search. Potentially relevant studies will be retrieved in full‐text version to be evaluated for inclusion by two authors working independently.

Data extraction and management

Two authors will independently extract data from the relevant studies using a standardized data collection form. Any disagreements will be resolved by discussion. If additional information is required the authors of the relevant study will be contacted.

Assessment of risk of bias in included studies

Two authors will independently assess the following.
1. Randomization.
2. Allocation concealment, this will be graded according to The Cochrane Collaboration standard scheme: grade A: adequate; grade B: unclear; grade C: inadequate; grade D: not used.
4. Blinding of outcome assessment.
5. Losses to follow up and treatment of withdrawals.
Sensitivity analysis will be performed to assess any major differences with regard to methodological quality.
Excluded studies will be listed in the table 'Characteristics of excluded studies' and reasons for exclusion given.

Data synthesis

We will use The Cochrane Collaboration software Review Manager (RevMan 5.0) for quantitative analysis. The method of meta‐analysis will be dependent on the nature of the outcomes. We will calculate dichotomous data using relative risk (RR) and 95% confidence intervals (CI). We will perform, where appropriate, pooled outcome measures for continuous data only where the same scale is used. We will calculate weighted mean differences (WMD) and 95% CI providing the pooled measure is at a similar time point. Where pooled analyses are not possible we will report the trial results of the individual studies separately. We will seek publication bias by using a funnel plot or other similar analytical methods. Other data will be presented as reported in the original trial.
We will test for heterogeneity by using the I‐squared (I2) statistic (Higgins 2002). We will consider an I2 statistic > 40% as significant heterogeneity but we plan to use a random‐effects model for all data synthesis. Sources of clinical heterogeneity will be sought and, where found, a sensitivity analysis will be performed. Preplanned subgroup analyses will be undertaken to compare: different age groups; different types of surgery, emergency or elective surgery; premedication adjuncts; intraoperative adjuncts; nitrous oxide or air; intravenous fluids or no fluids; surgical versus nonsurgical procedures such as magnetic resonance imaging (MRI), where there are sufficient numbers of studies.